Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Events & presentations
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
21 Sep 2016 - 22 Sep 2016
Cell&Gene Therapy Europe, Berlin, Germany
04 May 2016 - 07 May 2016
ASGCT, Washington, DC, US
01 May 2016 - 05 May 2016
ARVO 2016, Seattle (Wash), US
22 Mar 2016
4th annual Cell&Gene Investor Day, New York City
27 Feb 2016 - 03 Mar 2016
NANOS 42nd Annual Meeting, Tucson (AZ), US
25 Jan 2016 - 27 Jan 2016
Phacilitate Cell&Gene Therapy, Washington DC
11 Jan 2016 - 15 Jan 2016
JP Morgan 34th Annual Healthcare Conference, San Francisco (CA), US
14 Nov 2015 - 17 Nov 2015
AAO, November 14-17, 2015, Las Vegas (CA), US
02 Nov 2015 - 04 Nov 2015
BioEurope, November 2-4, 2015, Munich, Germany
17 Sep 2015 - 20 Sep 2015
ESGCT, September 17-20, 2015, Helsinki, Finland
View previous 9 articles
1
…
9
10
11
12
13
14
15
16
17
View next 9 articles
Go back to the page of the page
